180 related articles for article (PubMed ID: 2423937)
61. Pulmonary infiltrates associated with noncytotoxic drugs.
Rice KL
Semin Respir Infect; 1988 Sep; 3(3):229-39. PubMed ID: 3055114
[TBL] [Abstract][Full Text] [Related]
62. [The amiodarone lung].
Akoun G; Milleron B; Mayaud C
Rev Pneumol Clin; 1984; 40(1):41-5. PubMed ID: 6372047
[TBL] [Abstract][Full Text] [Related]
63. Amiodarone pulmonary toxicity: clinical and subclinical features.
Adams PC; Gibson GJ; Morley AR; Wright AJ; Corris PA; Reid DS; Campbell RW
Q J Med; 1986 May; 59(229):449-71. PubMed ID: 3763811
[TBL] [Abstract][Full Text] [Related]
64. Drug-induced pulmonary fibrosis.
Daba MH; El-Tahir KE; Al-Arifi MN; Gubara OA
Saudi Med J; 2004 Jun; 25(6):700-6. PubMed ID: 15195196
[TBL] [Abstract][Full Text] [Related]
65. Amiodaronoma: an unusual form of amiodarone-induced pulmonary toxicity.
Jarand J; Lee A; Leigh R
CMAJ; 2007 May; 176(10):1411-3. PubMed ID: 17485692
[No Abstract] [Full Text] [Related]
66. [Follow-up of blood and alveolar hyper-eosinophilia in pneumopathy induced by amiodarone].
Lavaud F; Cossart C; Tack V; Bonnaud G
Therapie; 1990; 45(1):49-51. PubMed ID: 2343439
[No Abstract] [Full Text] [Related]
67. Ozone air pollutants and lung damage.
Penha PD; Amaral L; Werthamer S
IMS Ind Med Surg; 1972 Mar; 41(3):17-20. PubMed ID: 4501506
[No Abstract] [Full Text] [Related]
68. [Drug induced lung diseases. A review].
Bakka A
Tidsskr Nor Laegeforen; 1978 Apr; 98(12):630-4, 37. PubMed ID: 26124
[No Abstract] [Full Text] [Related]
69. [Drug-induced pulmonary diseases].
Fink G; Rosenberg I; Spitzer SA
Harefuah; 1990 Jun; 118(11):664-8. PubMed ID: 2201612
[No Abstract] [Full Text] [Related]
70. Busulphan lung.
Woodliff HJ; Finlay-Jones LR
Med J Aust; 1972 Sep; 2(13):719-22. PubMed ID: 4507947
[No Abstract] [Full Text] [Related]
71. Radiological manifestations of drug-induced disease.
Ansell G
Clin Radiol; 1969 Apr; 20(2):133-48. PubMed ID: 4890533
[No Abstract] [Full Text] [Related]
72. Pharmacologic and other chemical causes of interstitial lung disease.
Martin WJ
Chest; 1991 Jul; 100(1):241-3. PubMed ID: 1711951
[No Abstract] [Full Text] [Related]
73. Drug-induced pulmonary disorders.
Takafuji S; Nakagawa T
Intern Med; 2004 Mar; 43(3):169-70. PubMed ID: 15098591
[No Abstract] [Full Text] [Related]
74. Delayed pulmonary edema and bronchospasm after accidental lacrimator exposure.
Vaca FE; Myers JH; Langdorf M
Am J Emerg Med; 1996 Jul; 14(4):402-5. PubMed ID: 8768166
[TBL] [Abstract][Full Text] [Related]
75. Migratory pulmonary infiltrates in a patient treated with sotalol.
Portel L; Hilbert G; Gruson D; Gbikpi-Benissan G; Cardinaud JP
Eur Respir J; 1998 Jul; 12(1):259-60. PubMed ID: 9701448
[No Abstract] [Full Text] [Related]
76. Pulmonary complications of drug therapy.
Brettner A; Heitzman ER; Woodin WG
Radiology; 1970 Jul; 96(1):31-8. PubMed ID: 5310247
[No Abstract] [Full Text] [Related]
77. [Drug-induced pulmonary diseases].
Kondo A
Nihon Rinsho; 1978 May; Suppl():1890-1. PubMed ID: 80465
[No Abstract] [Full Text] [Related]
78. Drug-induced pulmonary disorders.
Aronchick JM; Gefter WB
Semin Roentgenol; 1995 Jan; 30(1):18-34. PubMed ID: 7899880
[No Abstract] [Full Text] [Related]
79. Pulmonary infiltrates with eosinophilia due to naproxen.
Nader DA; Schillaci RF
Chest; 1983 Feb; 83(2):280-2. PubMed ID: 6822116
[No Abstract] [Full Text] [Related]
80. Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs.
Cooper JA; White DA; Matthay RA
Am Rev Respir Dis; 1986 Mar; 133(3):488-505. PubMed ID: 2869727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
